Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ventyx Biosciences (VTYX) has issued an announcement.
Ventyx Biosciences, Inc. has appointed Matthew Moore as its new Chief Operating Officer, effective May 16, 2024. Bringing a wealth of experience from his previous role as Chief Business Officer at Arcutis Biotherapeutics and other executive positions in the pharmaceutical sector, Moore is set to receive a $475,000 annual salary, with potential for a 40% bonus and stock options. He has also secured an agreement for severance benefits and relocation expenses, highlighting his crucial role in the company’s future operations.
See more insights into VTYX stock on TipRanks’ Stock Analysis page.